JAGSNPHARM investors hold onto their investments as it marginally outperforms
17 May, 20197 min read
JAGSNPHARM managed to marginally outperform the broader market today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.11% per day. Friday's performance of +1.01% was a significant outperformance compared to it's daily average.